博安生物2024中期报告

（ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） 股份代號: 6955 2013T-cellEngagerADC T 39 39 FCGHKFCG 3485 H 183171712–1716 9 100020118 97927 6955 www.boan-bio.com Bank of AmericaCitibank N.A., Singapore Branch 1. 20246 30362.920236 30261.2101.738.9%®(BA1101)®(BA6101) 2. 20246 3080.322.1%20236 3039.4%20246 302024 3. 20246 30282.620236 30124.478.6% 4. 20246 30134.220236 30117.117.114.6% 5. 20246 3085.8202363040.22023III T-cell EngagerADC T 2024 2024 202338.9%362.9®®®2,700®®®20245 BLA20245BA510120247BA9101BA6101BA1102III20241BA1104III(BA2101)IIBA1301BA1202 BA1106IBA1301FDAODDBA130220247BA510120248 20246 3030020243648 9,000L2,000L20241Boyuno®®ANVISAGMPANVISAPIC/SANVISA GMPBoyuno® 20241BA2101COPDBA-HIEXcell® ®BA1101VEGF® 20214®6 ®BA610160mgRANKG2® 202211® •20241IIIFDAEMAPMDAFDAEMAPMDAIIIBA6101BA1102®® ®BA1102120mgRANKG2® •20241IIIFDAEMA PMDAFDAEMA PMDAIIIBA6101BA1102®® •20245®GCTB1≥45kg® BA51011 (GLP-1)® BA5101®® •20243III •20245 •20248FDABA5101 BA9101® (nAMD)(DME)(RVO)(DR)(mCNV)(ROP) 202010BA9101 III1477BA9101BA9101BA9101 •20247 BA11041(PD-1)PD-1PD-L1PD-L2T® •202310BA1104IIIIII BA21014IL-4RIgG4 IL-4IL-13Th2IgETh2BA2101COPD(CSU)2BA2101BA210141IBA2101 •2023BA2101I20241BA2101II •20241BA2101BA2101COPDBA2101COPD BA1106IL-2CD25 BA1106CD25CD25CD25BA1106CD25FcIL-2BA1106 BA1106ADCCTregTBA1106PD-1BA1106IL-2TregBA1106(Nature)Scientific Reports •2023BA1106II BA1202CEA/CD3 BA1202TCD3CEACEA/CD3TCD3CD3CD3CD3+TT(Bispecific T-cell Engager, BiTE), CD3TCD3TTCD3PD-L1CEACAM5CEA BA1202CEATCD3FcCRSTCEA •2023BA1202II BA1301Claudin 18.2ADC BA1301Claudin 18.2Claudin 18.2 •2023BA1301II •20241BA1301FDAODDBA1301FDAODD BA1302CD228ADC CD228GPICD228 BA1302CD228ADCBA1302CD228BA-huMab®CD228sMFI2BA1302BNLD11BNLD11 BA1302BA1302CD228(PDX)BA1302 •20247BA1302CD228ADC T-cell EngagerADC CMCCMC CMC 20246 30300 3648 (Nature)(Cell Discovery)Antibody Therapeutics(Cancer Communications)15 QPQP84,4742,000L9,000L20246 30402 ®®® 28.2%332.520236 30259.3®® 20246 302102,700 20245®13.7%17.3%® ®BA9101BA910120244BA9101IIIBA91012024720241BA2101BA2101COPDBA2101 BA-HIEXcell®BA-HIEXcell® 20246 3061.7202312 3120246 30A202412 31 BA5101BA91012025 20252025BA6101BA1102FDA IL-4RBA2101II4I2025 ® 3BA5101BA9101 BA11043®BA6101BA1102 ADC ADC BA1102BA6101BA5101 20246 30362.920236 30261.2101.738.9%®(BA1101)®(BA6101) 20246 3080.322.1%202363039.4%20246 302024 20246 30282.620236 30124.478.6% 20246 3036.120236 301.734.4 20236 3026.620246 3024.3 20246 30134.220236 30117.117.114.6% 20246 3085.820236 3040.22023III 20246 3012.620236 306.3 20246 3020236 300.2 20246 3061.720236 30119.5 2024 20246 30172.1202312 31201.929.814.8%20246 30193.42023123159.7133.7202312 311.0920246 301.35 20246 30654.2202312 31396.220246 30202312 312021250.02026520246 3014.71.22%2.12%2024300 177.4476.82024630 20246 30202312 3130.0%47.0% 234.1202312 31225.0 20246 30 20246 30 20246 30 20246 30255.7 20246 3077720236 3074520246 3086.420236 3085.1 20246 305% 13.21 20244 12300,000,00074,387,153H20244 12 20248 726,655,6004.97%9.5020247 3120248 720248 2820248 23 20246 3020246 30 20246 30 241020246 30 20245 242898 13.51B(1) 20246 3020236 30 C1 20246 302 C.2.1 C.2.1 C32024630 20246 30XVXV78352 1.21,415,5484,720,0006,800,000 2.11,268,4881,800,0001,000,000 3.14,954,6322,480,0003,000,000 20246 30XV(i)352(ii) 20246 30XV23336 1.Luye HKLuye HKLuye HK 2.LuYe Investment35.42%LuYe InvestmentLuye Life SciencesLuYe InternationalLuye HoldingsLuye Life SciencesNelumbo70%NelumboGinkgoGinkgoShoreaLuYe InvestmentLuYeInternationalLuye HoldingsLuye Life SciencesNelumboGinkgoShorea 20246 30XV23336 Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 284420246 30343434 2410 34 20248 27 1,992,7561,670,037 1,391,7581,319,868 1. 20246 3034202312 31 2. 202312 31 161177 20202022 (a)1616 (b)20202022 202320241 1 (c)77 3. 4. 5. 6. 202420236 30 7. 20246 3020236 30 8. 509,278,0942023509,278,094 202420236 30 9. 503,000202312 31554,000 20246 306,087,000202312 3162,996,000926,913,000202312 31 9. 10. 90 20246 306,180,000202312 3112,290,000 11. 234,108,000202312 31225,008,000 12. 12. (a) 12. (b) 20246 30185,218,000202312 31210,273,000 20246 30427,904,000202312 31100,000,000 (c) 20246 303,141,000202312 311,647,000917,000202312 3115,852,000 12. (d) 13. 13. 20236 30 13. 14. 20248 726,655,6004.97%9.50202473120248 7